CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to enhance the diagnosis of lower respiratory tract infections by clinically validating a biomarker signature and developing a new point-of-need device, ImmunoDx™, for rapid testing. This innovation seeks to improve treatment accuracy and patient outcomes, particularly for older adults at risk of thes…
Lower respiratory tract infection (LRTI) is the 3rd leading cause of death worldwide.
In the EU 30 million incidents occur annually, with associated costs of €46 billion.
Older adults are at higher risk of developing LRTI, and therefore, in light of Europe's ageing population, the disease burden will increase.
Since most adult LRTIs are managed in the outpatient setting, innovative diagnostic tools for guiding treatment at the point-of-need (PON), would be impactful.MeMed identified a host-bioma…
MEMED DIAGNOSTICS LTD
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
